17 March 2003
Androgen and SHBG serum concentrations in late post-menopause women.
Piotr Skałba, Mariusz Wójtowicz, Jerzy SikoraMed Sci Monit 2003; 9(3): CR152-156 :: ID: 4724
Abstract
BACKGROUND: The purpose of our study was to evaluate androgen and SHBG concentration in the blood serum of late post-menopausal women. MATERIAL/METHODS: We examined women between 65 and 75 years of age and compared their results to those of a group of women in reproductive age. All the subjects, in addition to medical and gynecologic examinations, had determinations done of bound testosterone, free testosterone, androstenedione, dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulphate (DHEAS), sex hormone binding globulin (SHBG), and estradiol. RESULTS: The mean concentration of bound testosterone was found to be higher in postmenopausal women than in young women. The concentration of free testosterone did not vary, while the concentration of androstenedione was lower in the postmenopausal women, as were the DHEA and DHEAS concentrations. The mean SHBG concentration was higher in the postmenopausal women, and lower in obese postmenopausal women than in non-obese women. No differences were found in terms of the examined parameters between subjects with cardiovascular diseases and those without, or between smokers and non-smokers. CONCLUSIONS: The extinction of ovary function and aging of a woman is related to secondary changes of androgen concentrations in blood serum. In late postmenopausal women, the SHBG concentration increases, which is related to the increase of total testosterone concentration in blood serum. Obesity affects the reduction of SHBG concentration in blood serum in postmenopausal women. Cardiovascular diseases and smoking have no significant effect on androgen concentration and SHBG changes in blood serum in postmenopausal women.
Keywords: Androgens - blood, Androstenedione - blood, Dehydroepiandrosterone - blood, Menopause - blood, Sex Hormone-Binding Globulin - metabolism, Testosterone - blood
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952